About nexalin technology inc - NXL
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices help people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
NXL At a Glance
Nexalin Technology, Inc.
1776 Yorktown
Houston, Texas 77056
| Phone | 1-832-260-0222 | Revenue | 301.65K | |
| Industry | Medical Specialties | Net Income | -8,222,181.00 | |
| Sector | Health Technology | 2025 Sales Growth | 78.785% | |
| Fiscal Year-end | 12 / 2026 | Employees | 8 | |
| View SEC Filings |
NXL Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 30.324 |
| Price to Book Ratio | 2.856 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.648 |
| Enterprise Value to Sales | 17.981 |
| Total Debt to Enterprise Value | N/A |
NXL Efficiency
| Revenue/Employee | 37,705.875 |
| Income Per Employee | -1,027,772.625 |
| Receivables Turnover | 3.698 |
| Total Asset Turnover | 0.068 |
NXL Liquidity
| Current Ratio | 4.845 |
| Quick Ratio | 4.697 |
| Cash Ratio | 4.196 |
NXL Profitability
| Gross Margin | -543.353 |
| Operating Margin | -2,781.689 |
| Pretax Margin | -2,725.415 |
| Net Margin | -2,725.763 |
| Return on Assets | -185.643 |
| Return on Equity | -221.502 |
| Return on Total Capital | -219.376 |
| Return on Invested Capital | -221.502 |
NXL Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |